Furthermore, P4-treatment did not activate markers of ILC2s, including IL-13 and IL-33 production, or increase numbers of Tregs in the lungs during infection, suggesting that the induction of AREG in response to P4 may not be occurring in these immune cell populations. The gene discussed is AREG; the disease is infection.